Skip to main content
Clinical Trials/NCT03284632
NCT03284632CompletedNot Applicable

e-Cigarettes: Formaldehyde DNA Adducts, Oxidative Damage, and Potential Toxicity and Carcinogenesis

University of Minnesota1 site in 1 country217 target enrollmentStarted: July 11, 2017Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
217
Locations
1
Primary Endpoint
DNA Adducts

Study Overview

Brief Summary

This study will examine the level of toxicity of e-cigarette use compared to smokers and nonsmokers including inflammation markers, toxicant and carcinogen exposure. Additionally, the study will look at the effect of varying voltage levels for e-cigarette users.

Detailed Description

In this observational study, e-cigarette users, smokers, and non-users of e-cigarette or tobacco products (up to 134 per group) will be recruited from the Minneapolis-St. Paul area. This research will be conducted at the Tobacco Research Programs at the University of Minnesota. Subjects are screened for eligibility over the phone. If eligible after the phone screen, participants will be invited to attend orientation screening visit in the clinic where consent will be obtained and subjects will complete forms about their tobacco and e-cigarette use and medical history. Subjects who eligible will be asked to return for six visits over the course of six months.

At these appointments, subjects will provide biological specimen samples (buccal cells, urine and blood). Saliva will be collected before and after a smoking or vaping session. Non-users will only have 1 saliva collection.

Subjects will be asked for information pertaining to and e-cigarette and tobacco use and overall health.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Good physical health with no unstable medical conditions; Able to provide written informed consent; Stable and good mental health;
  • Meet criteria for 1 of three groups:
  • Regular smokers confirmed by CO;
  • E-cigarette users (exclusive e-cigarette use for 3 months); Non-Tobacco Users
  • Non-smokers

Exclusion Criteria

  • Unstable medical condition Not willing to attend visits

Outcomes

Primary Outcomes

DNA Adducts

Time Frame: 6 months

Formation of Formaldehyde DNA Adducts in oral cells before and after smoking or vaping

Secondary Outcomes

  • TNE(6 months)
  • Urinary 8-iso-PGF-2α(6 months)
  • Urinary PGEM(6 months)
  • C-reactive protein(6 months)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials